Zai Lab Ltd(ZLAB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZLAB Zai Lab Ltd

Market Closed 07-02 16:00:00 EDT

19.12

-0.03

-0.16%

盘后19.02

-0.10-0.52%

17:56 EDT

High19.44	Low18.89	Vol389.15K
Open19.21	D1 Closing19.15	Amplitude2.87%
Mkt Cap2.15B	Tradable Cap2.09B	Total Shares112.35M
T/O7.43M	T/O Rate0.36%	Tradable Shares109.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ZLAB","market":"US","secType":"STK","nameCN":"Zai Lab Ltd","latestPrice":19.12,"timestamp":1783022400000,"preClose":19.15,"halted":0,"volume":389148,"hourTrading":{"tag":"盘后","latestPrice":19.02,"preClose":19.12,"latestTime":"17:56 EDT","volume":6053,"amount":115675.69,"timestamp":1783029369391,"change":-0.1,"changeRate":-0.00523,"amplitude":0.00523},"delay":0,"changeRate":-0.0015665796344646258,"floatShares":109371942,"shares":112353700,"eps":-1.6209,"marketStatus":"Market Closed","change":-0.03,"latestTime":"07-02 16:00:00 EDT","open":19.21,"high":19.44,"low":18.89,"amount":7427288.4567,"amplitude":0.028721,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.6209,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":1,"adrRate":10,"listingDate":1505880000000,"exchange":"NASDAQ","adjPreClose":19.15,"preHourTrading":{"tag":"盘前","latestPrice":19.24,"preClose":19.15,"latestTime":"09:29 EDT","volume":1596,"amount":30521.28156,"timestamp":1782998999999,"change":0.09,"changeRate":0.0047,"amplitude":0.04752},"postHourTrading":{"tag":"盘后","latestPrice":19.02,"preClose":19.12,"latestTime":"17:56 EDT","volume":6053,"amount":115675.69,"timestamp":1783029369391,"change":-0.1,"changeRate":-0.00523,"amplitude":0.00523},"volumeRatio":0.39241039867624633,"impliedVol":0.6706,"impliedVolPercentile":0.5578},"requestUrl":"/m/hq/s/ZLAB/tweets","defaultTab":"tweets","newsList":[{"id":"2648699148","title":"Does Zai Lab's (ZLAB) Latest Oncology Designations Reframe Its Long-Term Pipeline Value Proposition?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648699148","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648699148?lang=en_us&edition=fundamental","pubTime":"2026-07-04 19:27","pubTimestamp":1783164423,"startTime":"0","endTime":"0","summary":"Zai Lab recently received Orphan Drug Designation from the European Medicines Agency for zocilurtatug pelitecan, a DLL3-targeting antibody-drug conjugate for pulmonary neuroendocrine carcinomas, alongside China’s approval of its Biologics License Application for TIVDAK in recurrent or metastatic cervical cancer.\nTogether, these regulatory milestones highlight growing recognition of Zai Lab’s oncology portfolio and may enhance the commercial and clinical relevance of its pipeline.\nWe will now...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/does-zai-labs-zlab-latest-oncology-designations-reframe-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/does-zai-labs-zlab-latest-oncology-designations-reframe-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4548","BK4139","BK4585","BK4531","LU2488822045.USD","ZLAB","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647388305","title":"Is Zai Lab (ZLAB) A Bargain Following Its Push For More Product Launches?","url":"https://stock-news.laohu8.com/highlight/detail?id=2647388305","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647388305?lang=en_us&edition=fundamental","pubTime":"2026-06-29 23:16","pubTimestamp":1782746212,"startTime":"0","endTime":"0","summary":"Zai Lab (ZLAB) stock moved after recent trading left it around $18, drawing attention to how its current valuation lines up with its multi-therapy biopharmaceutical portfolio and ongoing commercialization efforts.\nSee our latest analysis for Zai Lab.\nOver the past year, Zai Lab’s share price return has been mixed, with short term moves around the recent US$18 level contrasting with a 1 year total shareholder return that has fallen 48.53%, while the 5 year total shareholder return is down...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/is-zai-lab-zlab-a-bargain-following-its-push-for-more-produc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/is-zai-lab-zlab-a-bargain-following-its-push-for-more-produc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ZLAB","BK4139","LU2488822045.USD","BK4588","BK4585","BK4548","BK4526","BK4531"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157905267","title":"Zai Lab Ltd Announces Restricted Share Unit Grant","url":"https://stock-news.laohu8.com/highlight/detail?id=1157905267","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157905267?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:10","pubTimestamp":1782130222,"startTime":"0","endTime":"0","summary":"Zai Lab Ltd (ASX: 09688) has issued a corporate announcement regarding the grant of restricted share units.The company, on June 17, 2026 (Eastern Time), granted a number of restricted share units to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4585","BK1161","ZLAB","BK1588","BK1574","BK4531","09688","BK4139","BK4526","BK4588","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644605790","title":"Why Zai Lab (ZLAB) Is Up 6.5% After Dual TIVDAK China Approval and EU Orphan Win – And What's Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2644605790","media":"Simply Wall St.","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644605790?lang=en_us&edition=fundamental","pubTime":"2026-06-20 17:30","pubTimestamp":1781947812,"startTime":"0","endTime":"0","summary":"Zai Lab has recently gained China NMPA approval for TIVDAK in recurrent or metastatic cervical cancer and secured European Orphan Drug Designation for zocilurtatug pelitecan (zoci) in pulmonary neuroendocrine carcinomas, extending its oncology footprint across major markets.\nThese regulatory milestones highlight Zai Lab’s growing role as a bridge for advanced antibody-drug conjugates into Greater China and specialized cancer indications globally.\nWe’ll now examine how TIVDAK’s China...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/why-zai-lab-zlab-is-up-65-after-dual-tivdak-china-approval-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/why-zai-lab-zlab-is-up-65-after-dual-tivdak-china-approval-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ZLAB","BK4139","LU2488822045.USD","BK4588","BK4585","BK4156","BK4548","BK4526","BK4531"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120665365","title":"Zai Lab Shares Defy Market Trend with 7% Surge Following European Orphan Drug Designation for Zoci","url":"https://stock-news.laohu8.com/highlight/detail?id=1120665365","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120665365?lang=en_us&edition=fundamental","pubTime":"2026-06-18 10:32","pubTimestamp":1781749973,"startTime":"0","endTime":"0","summary":"Shares of Zai Lab (09688) have risen against the broader market trend, gaining over 7%. At the time of writing, the stock was up 6.27% to HK$14.4, with a trading volume of HK$72.5449 million....","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4548","09688","BK4526","BK4531","BK4585","LU2488822045.USD","BK1161","BK4139","BK1588","BK4588","BK1574","ZLAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644795428","title":"Zai Lab (ZLAB) Stock Could Be 47.5% Undervalued After China Approved TIVDAK","url":"https://stock-news.laohu8.com/highlight/detail?id=2644795428","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644795428?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:27","pubTimestamp":1781648820,"startTime":"0","endTime":"0","summary":"Zai Lab (ZLAB) stock is in focus after China’s National Medical Products Administration approved TIVDAK for adults with recurrent or metastatic cervical cancer whose disease progressed on or after chemotherapy.\nSee our latest analysis for Zai Lab.\nThe NMPA approval for TIVDAK comes after a mixed stretch for Zai Lab, with the stock showing a 1-day share price return of 3.87% and a 7-day share price return of 7.58%, yet a 1-year total shareholder return that declined 56.36%. This suggests...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/zai-lab-zlab-stock-could-be-475-undervalued-after-china-appr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/zai-lab-zlab-stock-could-be-475-undervalued-after-china-appr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","LU2488822045.USD","BK4531","BK4526","BK4588","ZLAB","BK4585","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643875747","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2643875747","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643875747?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:58","pubTimestamp":1781614712,"startTime":"0","endTime":"0","summary":"Healthcare stocks were steady pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF  up 0.3% and the iShares Biotechnology ETF  unchanged.Zai Lab  stock was up more than 2% after the company said the European Medicines Agency has granted orphan drug designation to its experimental therapy, zocilurtatug pelitecan, for the treatment of pulmonary neuroendocrine carcinomas, a type of lung cancer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4526","LABU","BK4588","XBI","BK4585","BK4548","XLV","ZLAB","BK4139","BK4531","LU2488822045.USD","IBB","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643510567","title":"Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2643510567","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643510567?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:34","pubTimestamp":1781609689,"startTime":"0","endTime":"0","summary":"Zai Lab  said Tuesday that the European Medicines Agency  has granted orphan drug designation to its experimental therapy, zocilurtatug pelitecan, for the treatment of pulmonary neuroendocrine carcinomas, a type of lung cancer.The company said the designation follows a recommendation from the EMA's Committee for Orphan Medicinal Products, which cited preliminary clinical data suggesting that the therapy may offer a clinically meaningful advantage over currently approved treatments for relapsed or refractory extensive-stage small cell lung cancer, including the potential for durable responses.Zai Lab said the orphan designation provides regulatory incentives that may support the therapy's development, including potential market exclusivity upon approval, reduced regulatory fees, and enhanced regulatory support.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMA","BK4531","BK4139","BK4548","BK4585","BK4156","BK4526","LU2488822045.USD","ZLAB","BK4081","BK4588","EMA.AU","BK7129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153707094","title":"Zai Lab Shares Surge on Dual Drug Approvals and Market Launches","url":"https://stock-news.laohu8.com/highlight/detail?id=1153707094","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153707094?lang=en_us&edition=fundamental","pubTime":"2026-06-10 14:52","pubTimestamp":1781074360,"startTime":"0","endTime":"0","summary":"Shares of Zai Lab Ltd (ASX: ZLAB) have experienced a notable increase, rising over 4% in recent trading. The company's stock price reached HK$13.07 with a trading volume of HK$156 million. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","ZLAB","BK4139","BK1161","BK4585","BK4526","BK4531","LU2488822045.USD","06978","BK1574","BK4588","159992","09688","IPOS","BK4548","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642450063","title":"Zai Lab Says China Approves Tivdak for Cervical Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2642450063","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642450063?lang=en_us&edition=fundamental","pubTime":"2026-06-09 15:56","pubTimestamp":1780991814,"startTime":"0","endTime":"0","summary":"Zai Lab  received approval from China's National Medical Products Administration for Tivdak to treat adults with recurrent or metastatic cervical cancer whose disease progressed on or after chemotherapy, the company said Monday.The approval was supported by results from a phase 3 trial in which Tivdak showed a 45% reduction in the risk of death compared to chemotherapy in the China subpopulation, Zai Lab said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4526","ZLAB","BK4548","BK4531","BK4588","LU2488822045.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118644479","title":"Zai Lab Ltd Announces Grant of 5,000 Restricted Share Units","url":"https://stock-news.laohu8.com/highlight/detail?id=1118644479","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118644479?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:28","pubTimestamp":1780493292,"startTime":"0","endTime":"0","summary":"Zai Lab Ltd (ASX: 09688) has disclosed the issuance of 5,000 restricted share units.The grant was made on June 1, 2026, Eastern Time, under the company's 2024 Equity Incentive Plan.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688","BK4588","BK4139","BK1161","BK1574","BK4526","BK4585","ZLAB","BK4531","BK4548","LU2488822045.USD","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637322496","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (HCA) and Zai Lab (ZLAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637322496","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637322496?lang=en_us&edition=fundamental","pubTime":"2026-05-23 20:30","pubTimestamp":1779539405,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on HCA Healthcare (HCA) and Zai Lab (ZLAB). HCA Healthcare (HCA) J.P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-hca-healthcare-hca-and-zai-lab-zlab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-hca-healthcare-hca-and-zai-lab-zlab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2355687059.USD","XBI","LU0203345920.USD","LU0310799852.SGD","LU0980610538.SGD","SG9999014021.USD","IE00B775SV38.USD","HCA","LU1150488135.SGD","BK4588","LU0187121727.USD","LU1267930573.SGD","BK4185","LU2488822045.USD","LU0128525929.USD","BK4531","SG9999014013.SGD","LU0882574055.USD","LABU","BK4585","LU1489326972.SGD","LU0130102774.USD","XLV","LU0211327993.USD","BK4581","LU1084165304.USD","LU1119994496.HKD","SG9999014039.USD","LU2244417387.USD","IE00B3S45H60.SGD","LU0114720955.EUR","LU0310800379.SGD","LU0878866978.SGD","BK4504","LU0029864427.USD","LU1150488218.USD","LU0211328371.USD","LU1261432733.SGD","LU0648001328.SGD","LU1267930490.SGD","SG9999014005.SGD","LU0985489474.SGD","ZLAB","LU0203347892.USD","LU0708994859.HKD","LU1201861249.SGD","LU0068578508.USD","LU0868494617.USD","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637039497","title":"Zai Lab President, COO Josh Smiley to Depart","url":"https://stock-news.laohu8.com/highlight/detail?id=2637039497","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637039497?lang=en_us&edition=fundamental","pubTime":"2026-05-22 16:29","pubTimestamp":1779438556,"startTime":"0","endTime":"0","summary":"Zai Lab  President and Chief Operating Officer Josh Smiley will leave the company effective May 22 as part of changes to its senior leadership team, the company said Friday.The company expects several 2026 milestones, including zoci data in small cell lung cancer and neuroendocrine carcinomas, as well as initial Phase 1/1b data for ZL-1503, it added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU1992135472.HKD","BK4548","BK4585","LU1992135399.USD","LU2211815571.USD","LU2272731600.USD","BK4198","BK4588","GB00BDT5M118.USD","BK4526","LU2488822045.USD","COO","ZLAB","BK4531","LU2272731782.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135998116","title":"Zai Lab Announces Leadership Change: President and COO to Step Down","url":"https://stock-news.laohu8.com/highlight/detail?id=1135998116","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135998116?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:28","pubTimestamp":1779409696,"startTime":"0","endTime":"0","summary":"Zai Lab Ltd (09688) has announced a change in its executive leadership. According to a filing, the company's board of directors has determined that Mr. Josh Smiley will no longer serve as President...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4548","BK4588","BK1574","BK1161","BK4526","BK1588","09688","BK4585","LU2488822045.USD","ZLAB","BK4531"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637741350","title":"Zai Lab announces departure of COO Josh Smiley","url":"https://stock-news.laohu8.com/highlight/detail?id=2637741350","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637741350?lang=en_us&edition=fundamental","pubTime":"2026-05-22 06:30","pubTimestamp":1779402613,"startTime":"0","endTime":"0","summary":"Zai Lab (ZLAB) announced changes to its senior leadership team aimed at strengthening operational performance and efficiency. As part of these chan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zai-lab-announces-departure-of-coo-josh-smiley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zai-lab-announces-departure-of-coo-josh-smiley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2272731600.USD","LU1992135472.HKD","ZLAB","GB00BDT5M118.USD","LU2272731782.SGD","BK4198","COO","LU1992135399.USD","BK4585","BK4588","LU2211815571.USD","BK4531","LU2488822045.USD","BK4139","BK4548","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636882399","title":"CICC Keeps Their Buy Rating on Zai Lab Ltd (1ZLB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636882399","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636882399?lang=en_us&edition=fundamental","pubTime":"2026-05-19 13:15","pubTimestamp":1779167756,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from CICC maintained a Buy rating on Zai Lab Ltd, with a price target of HK$20.20. The company’s shares closed last...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cicc-keeps-their-buy-rating-on-zai-lab-ltd-1zlb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cicc-keeps-their-buy-rating-on-zai-lab-ltd-1zlb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZLAB","CICC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636744074","title":"Asian Equities Traded in the US as American Depositary Receipts Lower in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2636744074","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636744074?lang=en_us&edition=fundamental","pubTime":"2026-05-18 22:44","pubTimestamp":1779115441,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were lower Monday morning, declining 0.48% to 2,833.93 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by streaming music service Tencent Music Entertainment Group  and game live-streaming service DouYu International , which rose 7.1% and 3.8% respectively. They were followed by healthcare platform 111  and lender Mitsubishi UFJ Financial Group , which were up 1.9% and 1.8% respectively.The decliners from North Asia were led by Eason Technology  and online game developer The9 , which shed 17% and 6.9% respectively. They were followed by biopharmaceutical company Zai Lab  and semiconductor company ASE Technology , which lost 6.8% and 6.5% respectively.From South Asia, the gainers were led by telecommunications operators Telekomunikasi Indonesia  and PLDT , which rose 4% and 1.8% respectively. It was  followed by HDFC Bank , which increased 1.5%.The decliners from South Asia were computer hardware maker Ca","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0528227936.USD","LU0348816934.USD","LU2663582299.SGD","09688","BK4139","LU0431992006.USD","SG9999014005.SGD","LU0348744763.USD","DXF","LU0868486357.SGD","NCTY","LU2279701549.SGD","BK4207","BK4543","BK4531","LU0708995666.HKD","LU0797268264.HKD","CAN","BK4089","BK4115","LU2039709279.SGD","LU1791710400.SGD","BK4132","BK4571","LU2177674079.SGD","BK4566","BK4164","HDB","LU0456842615.SGD","LU0307460401.USD","ZLAB","BK4577","LU2265009873.SGD","LU1854104046.USD","IE00B0JY6M65.USD","LU1267930656.SGD","BK7095","IE00BYTNYM70.SGD","LU0269904917.USD","LU0197229882.USD","IE00BYTNYN87.SGD","LU2008162690.USD","01698","LU0828238088.HKD","LU1023057109.AUD","IE00B12V2V27.USD","LU0287143357.SGD","BK4107","BK4509","BK7039","TME","LU0509642566.USD","BK7502","BK7096","LU1804176565.USD","BK4585","BK4503","LU1854103824.USD","LU0536402901.SGD","SIFY","IE00B7N09G41.SGD","BK4523","LU0918141887.USD","LU1105468828.SGD","BK4023","LU0197773160.USD","LU0630378692.HKD","TLK","LU2488822045.USD","SG9999011746.SGD","YI","PHI","IE0001KFT4U8.USD","BK4548","LU0359202008.SGD","BK4141","LU2226246903.HKD","BK7508","LU1791710582.SGD","BK4595","BK4085","LU0390134368.USD","BK4170","LU1805238398.USD","SG9999014021.USD","BK4526","IE00BYQNZ168.SGD","BK4565","LU0630378429.USD","BK4552","SG9999014039.USD","BK4108","BK4563","LU1282648689.USD","DOYU","LU0197773673.USD","LU0541502299.USD","LU1508157978.USD","LU0231203729.USD","BK4535","BK4600","LU0359201612.USD","LU0918141705.HKD","LU0348814723.USD","BK4117","BK4128","ASX","BK4513","LU0541501648.USD","SG9999014013.SGD","BK4588","MUFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118963481","title":"Zai Lab Shares Surge Over 5% in Late Trading as Zoci Receives FDA Fast Track Designation for Extrapulmonary Neuroendocrine Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1118963481","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118963481?lang=en_us&edition=fundamental","pubTime":"2026-05-15 17:41","pubTimestamp":1778838082,"startTime":"0","endTime":"0","summary":"Zai Lab (09688) saw its shares climb more than 5% in late trading. At the time of writing, the stock was up 4.89% to HK$16.1, with a turnover of HK$247 million. The move follows the company's recent...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK1161","VXUS","09688","ZLAB","BK4585","BK4588","BK4531","BK1588","LU2488822045.USD","BK1574","BK4139","BK4548","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152000413","title":"Zai Lab Announces Grant of Stock Options and Restricted Stock Units","url":"https://stock-news.laohu8.com/highlight/detail?id=1152000413","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152000413?lang=en_us&edition=fundamental","pubTime":"2026-05-12 16:38","pubTimestamp":1778575104,"startTime":"0","endTime":"0","summary":"Zai Lab (09688) announced that on the grant date, the company issued 136,800 stock options (in the form of American Depositary Shares) and 75,300 restricted stock units (in the form of American...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09688","ZLAB","BK4585","BK4588","BK4531","BK1588","LU2488822045.USD","BK1574","BK4139","BK4548","BK4526"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1119499780","title":"Zai Lab Shares Surge Over 5% in Early Trading as Zoci Receives FDA Fast Track Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=1119499780","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119499780?lang=en_us&edition=fundamental","pubTime":"2026-05-12 11:01","pubTimestamp":1778554875,"startTime":"0","endTime":"0","summary":"Zai Lab (09688) saw its shares rise more than 5% in early trading. At the time of writing, the stock was up 2.38% to HK$15.49, with a turnover of HK$73.7089 million. On the news front, on May 11,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09688","BK1119","ZLAB","BK4585","BK4588","BK4531","BK1588","LU2488822045.USD","BK1574","BK4139","BK4548","BK4526"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":0.0324},{"period":"1month","weight":0.1149},{"period":"3month","weight":-0.0632},{"period":"6month","weight":0.1033},{"period":"1year","weight":-0.4613},{"period":"ytd","weight":0.0839}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.085823},{"month":2,"riseRate":0.555556,"avgChangeRate":0.030708},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.076257},{"month":4,"riseRate":0.444444,"avgChangeRate":0.02394},{"month":5,"riseRate":0.444444,"avgChangeRate":0.004882},{"month":6,"riseRate":0.555556,"avgChangeRate":0.07528},{"month":7,"riseRate":0.555556,"avgChangeRate":0.005082},{"month":8,"riseRate":0.625,"avgChangeRate":0.000651},{"month":9,"riseRate":0.375,"avgChangeRate":-0.055585},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.047464},{"month":11,"riseRate":0.555556,"avgChangeRate":0.101421},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.029495}],"exchange":"NASDAQ","name":"Zai Lab Ltd","nameEN":"Zai Lab Ltd","securityTypeName":"DR","adrRate":"1:10"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zai Lab Ltd(ZLAB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Zai Lab Ltd(ZLAB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Zai Lab Ltd,ZLAB,Zai Lab Ltd股票,Zai Lab Ltd股票老虎,Zai Lab Ltd股票老虎国际,Zai Lab Ltd行情,Zai Lab Ltd股票行情,Zai Lab Ltd股价,Zai Lab Ltd股市,Zai Lab Ltd股票价格,Zai Lab Ltd股票交易,Zai Lab Ltd股票购买,Zai Lab Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zai Lab Ltd(ZLAB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Zai Lab Ltd(ZLAB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}